Category: iCad Inc.Syndicate content

Intersect ENT hopes to raise $80 million in newly registered initial public offering | Medtech funding for the week of June 23, 2014

June 27, 2014 by MassDevice

Here's a look at some of the top funding stories for medical device companies this week: Intersect ENT registers $80M IPO for sinus implants; Mitralign raises another $8M; Device makers tally $67M in Pentagon deals; EndoShape raises $6.8M for vascular plugs and coils; EMBA Medical's still working on its $3M funding round

Intersect ENT registers $80M IPO for sinus implants

June 24, 2014 by Arezu Sarvestani

Intersect ENT registers $80M IPO for sinus tech

Device makers tally $67M in Pentagon deals

June 23, 2014 by Arezu Sarvestani

Hologic, Welch Allyn, InVivo, Digirad and ICAD claim nearly $67 million in medtech contracts with the Dept. of Defense.

Device makers land $56M in Pentagon deals

The Defense Dept. handed out some $66.7 million in supply contracts to 5 medical device makers, covering Pap test kits, radiology and patient monitoring systems.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

iCad soars on Medicare reimbursement nod | Wall Street Beat

November 5, 2012 by MassDevice staff

Shares of medical device company iCad soar nearly 36% on a Medicare reimbursement nod.

MassDevice.com Wall Street Beat

iCad (NSDQ:ICAD) shares nearly doubled their value on Wall Street today after the medical device company said the Centers for Medicare & Medicaid approved a big increase in the reimbursement rate for its Xoft Axxent brachytherapy device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare closes enrollment in destination therapy trial for heart pump | Wall Street Beat

May 9, 2012 by MassDevice staff

HeartWare announced that it completed enrollment in a 450-patient clinical trial considering its HVAD pump as a destination therapy for patients with advanced heart failure; also, 2011 was a good year for angel investment; Bayer considers ditching diabetes business; iCad gets a stay of execution from Nasdaq delisting; INC Research expands a electronic data management partnership with Medidata; and Kimberly Clark renews a sterilization wrap contract with HealthTrust; plus, a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

HeartWare International (NSDQ:HTWR) completed enrollment in a 450-patient pivotal trial considering its ventricular assist system as a destination therapy for patients with advanced heart failure.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abbott brass takes pay cuts | Personnel Moves

March 16, 2012 by MassDevice staff

The top executives at Abbott see their pay packages decline by a collective 24%; also, Allezoe replaces suspect secretary White; Stereotaxis COO/CTO steps down; and iCad holds on to marketing SVP.

MassDevice.com Personnel Moves

The top brass at Abbott (NYSE:ABT) saw their 2011 pay packages reduced by a collective 23.9%, ranging from a 6.1% cut for chairman & CEO Miles White to a whopping 26.9% hit for pharma head Richard Gonzalez.

VCs press Senate on "IPO On Ramp" bill | Wall Street Beat

March 12, 2012 by MassDevice staff

The venture capital industry backs a push for passage of a bill that would make it easier for small companies to go public; also, VCs shift focus from high-tech med-tech; S&P affirms Boston Scientific's BBB rating; Allezoe CEO gets threats over PR policy; angels in America spent more on device makers last year; Flextronics buys Stellar Microelectronics; Philips Healthcare wins U.S. Army training contract; OTC exchange lists Avita Medical; iCad wins NASDAQ reprieve; Premier issues new GPO deals; plus, a Funding Roundup and analysts' ups and downs.

MassDevice.com Wall Street Beat

The National Venture Capital Assn. is spearheading a drive to get a bill through the U.S. Senate that would make it easier for small companies to raise money by going public.

The "IPO On Ramp" measure would ease the regulatory requirements for IPOs and temporarily reduce the reporting burdens imposed by the Sarbanes-Oxley Act.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific ties employee bonuses to overall company performance | Personnel Moves

March 5, 2012 by MassDevice staff

Boston Scientific reconfigures its employee bonus program to allocate rewards from a single company-side pool, the value of which is tied to the company's overall performance for the year.

Carrot dangling from a stick

Boston Scientific (NYSE:BSX) employees could see their annual bonus payments shrink or grow based on the device maker's adjusted earnings per share and global sales by the end of the year, thanks to a new performance incentive plan for 2012.

The Natick, Mass.-based med-tech titan reconfigured its employee reward system, tying the total potential payout for all regions and division into a single pool, the value of which fluctuates along with the company's performance in 2012.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp